[{"Assets_0_Q2_USD":68427000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1772000000.0,"NetIncomeLoss_1_Q2_USD":1006000000.0,"NetIncomeLoss_2_Q2_USD":1678000000.0,"StockholdersEquity_0_Q2_USD":31686000000.0,"EarningsPerShareBasic_1_Q2_USD":0.57,"EarningsPerShareBasic_2_Q2_USD":0.94,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1768904000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1766182000.0,"Ticker":"ABT","CIK":"1800","name":"ABBOTT LABORATORIES","OfficialName":"Abbott Laboratories Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"211582602395.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"SP500","filed":"20190731"}]